Kavya Rakhra

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The dependence on the overexpression of a single oncogene constitutes an exploitable weakness for molecular targeted therapy. These drugs can produce dramatic tumor regression by targeting the driving oncogene, but relapse often follows. Understanding the complex interactions of the tumor's multifaceted response to oncogene inactivation is key to tumor(More)
  • 1